|
Codorphone
|
|
| Systematic (IUPAC) name | |
| (1S,13R,16S,17R)- 4-(cyclopropylmethyl)- 16-ethyl- 10-methoxy- 12-oxa- 4-azapentacyclo [9.6.1.01,13.05,17.07,18] octadeca- 7(18),8,10- trien- 14-one | |
| Identifiers | |
| CAS number | |
| ATC code | none |
| PubChem | |
| Chemical data | |
| Formula | C23H29NO3 |
| Mol. mass | 367.481 g/mol |
| SMILES | & |
| Synonyms | (5α,8β)-17- Cyclopropylmethyl- 4,5-epoxy- 8-ethyl- 3-methoxy- morphinan- 6-one |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Codorphone (Conorphone) is an opioid analgesic drug. It is an analogue of hydrocodone substituted with an 8-ethyl group and an N-cyclopropylmethyl group. It is a mixed agonist-antagonist at the μ-opioid receptor, and is slightly more potent than codeine in analgesic effects but associated with somewhat greater side effects.[1]
References
- ^ Dionne RA, Wirdezk PR, Butler DP, Fox PC. Comparison of conorphone, a mixed agonist-antagonist analgesic, to codeine for postoperative dental pain. Anesthesia Progress. 1984 Mar-Apr;31(2):77-81. PMID 6597688
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)




